FDA Device recall Z-2278-2012
EXCELART Vantage, Atlas, and Titan MRI Systems, MRT-1503 and MRT-1504
- FDA Device
- Class II
- terminated
- Published 2012-09-05
On 2012-09-05 the FDA classified a Class II recall of EXCELART Vantage, Atlas, and Titan MRI Systems, MRT-1503 and MRT-1504 by Toshiba American Medical Systems, citing the status display in the sequence queue window may not change from "Current" to "Done".
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2278-2012 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2008-05-13 |
| Published | 2012-09-05 |
| Last updated | 2026-09-13 11:53 UTC |
| Company | Toshiba American Medical Systems |
| Distribution | US |
Product
EXCELART Vantage, Atlas, and Titan MRI Systems, MRT-1503 and MRT-1504. Imaging of the Whole Body, Fluid Visualization, 2D/3D Imaging, MR Angiography/MR Vascular Imaging, Blood Oxygenation Level Dependent Imaging, Perfusion I Diffusion Imaging, and Proton Spectroscopy.
Reason
The status display in the sequence queue window may not change from "Current" to "Done".
Identifiers
| code_info | Models MRT-1503 and MRT-1504 " MRT-1503 systems with software V9.01 *R240 through V9.20*R242 " MRT-1504 systems with software V9.21 *R24 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2278-2012%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.